Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | OCGN |
---|---|---|
09:32 ET | 136134 | 2.29 |
09:34 ET | 93417 | 2.28 |
09:36 ET | 90858 | 2.2628 |
09:38 ET | 34155 | 2.2501 |
09:39 ET | 67524 | 2.27 |
09:41 ET | 29254 | 2.27 |
09:43 ET | 12238 | 2.265 |
09:45 ET | 21999 | 2.245 |
09:48 ET | 22957 | 2.22 |
09:50 ET | 47288 | 2.24 |
09:52 ET | 15291 | 2.24 |
09:54 ET | 17579 | 2.23 |
09:56 ET | 25859 | 2.24 |
09:57 ET | 18489 | 2.27 |
09:59 ET | 14539 | 2.26 |
10:01 ET | 13738 | 2.25 |
10:03 ET | 21246 | 2.245 |
10:06 ET | 32465 | 2.255 |
10:08 ET | 32091 | 2.24 |
10:10 ET | 5553 | 2.2475 |
10:12 ET | 45235 | 2.235 |
10:14 ET | 26432 | 2.24 |
10:15 ET | 13175 | 2.255 |
10:17 ET | 22890 | 2.2392 |
10:19 ET | 20582 | 2.24 |
10:21 ET | 49477 | 2.215 |
10:24 ET | 25439 | 2.235 |
10:26 ET | 16202 | 2.235 |
10:28 ET | 5329 | 2.25 |
10:30 ET | 45905 | 2.275 |
10:32 ET | 35834 | 2.28 |
10:33 ET | 28969 | 2.27 |
10:35 ET | 22223 | 2.2737 |
10:37 ET | 12069 | 2.275 |
10:39 ET | 9133 | 2.27 |
10:42 ET | 22928 | 2.265 |
10:44 ET | 23144 | 2.265 |
10:46 ET | 6122 | 2.26 |
10:48 ET | 15900 | 2.2381 |
10:50 ET | 3308 | 2.235 |
10:51 ET | 11729 | 2.22 |
10:53 ET | 37746 | 2.2096 |
10:55 ET | 11683 | 2.205 |
10:57 ET | 9496 | 2.2 |
11:00 ET | 24272 | 2.19 |
11:02 ET | 31916 | 2.1899 |
11:04 ET | 5459 | 2.195 |
11:06 ET | 12164 | 2.185 |
11:08 ET | 4141 | 2.18 |
11:09 ET | 20551 | 2.175 |
11:11 ET | 35298 | 2.165 |
11:13 ET | 19806 | 2.16 |
11:15 ET | 10574 | 2.165 |
11:18 ET | 16446 | 2.1571 |
11:20 ET | 5572 | 2.155 |
11:22 ET | 68105 | 2.145 |
11:24 ET | 62581 | 2.145 |
11:26 ET | 22331 | 2.148 |
11:27 ET | 27063 | 2.155 |
11:29 ET | 2980 | 2.15 |
11:31 ET | 5580 | 2.15 |
11:33 ET | 6733 | 2.155 |
11:36 ET | 25321 | 2.14 |
11:38 ET | 6400 | 2.15 |
11:40 ET | 41426 | 2.14 |
11:42 ET | 17324 | 2.15 |
11:44 ET | 19256 | 2.15 |
11:45 ET | 15418 | 2.145 |
11:47 ET | 11113 | 2.135 |
11:49 ET | 1837 | 2.13 |
11:51 ET | 26958 | 2.135 |
11:54 ET | 74501 | 2.135 |
11:56 ET | 16726 | 2.145 |
11:58 ET | 45832 | 2.1475 |
12:00 ET | 14510 | 2.14 |
12:02 ET | 1900 | 2.13 |
12:03 ET | 1642 | 2.13 |
12:05 ET | 2561 | 2.135 |
12:07 ET | 3140 | 2.1375 |
12:09 ET | 66125 | 2.105 |
12:12 ET | 50053 | 2.1089 |
12:14 ET | 4710 | 2.115 |
12:16 ET | 26981 | 2.11 |
12:18 ET | 6172 | 2.1101 |
12:20 ET | 973 | 2.11 |
12:21 ET | 5450 | 2.1181 |
12:23 ET | 36704 | 2.125 |
12:25 ET | 2610 | 2.1292 |
12:27 ET | 41011 | 2.105 |
12:30 ET | 5794 | 2.11 |
12:32 ET | 20236 | 2.105 |
12:34 ET | 27970 | 2.1199 |
12:36 ET | 19989 | 2.115 |
12:38 ET | 9674 | 2.1087 |
12:39 ET | 31716 | 2.095 |
12:41 ET | 44043 | 2.085 |
12:43 ET | 49025 | 2.0833 |
12:45 ET | 14935 | 2.075 |
12:48 ET | 9474 | 2.075 |
12:50 ET | 35356 | 2.1 |
12:52 ET | 26216 | 2.0801 |
12:54 ET | 9410 | 2.08 |
12:56 ET | 22361 | 2.0863 |
12:57 ET | 9196 | 2.085 |
12:59 ET | 3241 | 2.09 |
01:01 ET | 17163 | 2.075 |
01:03 ET | 21720 | 2.09 |
01:06 ET | 10818 | 2.085 |
01:08 ET | 11742 | 2.075 |
01:10 ET | 9850 | 2.08 |
01:12 ET | 1700 | 2.07 |
01:14 ET | 14107 | 2.065 |
01:15 ET | 22162 | 2.07 |
01:17 ET | 5825 | 2.065 |
01:19 ET | 5177 | 2.06 |
01:21 ET | 21360 | 2.06 |
01:24 ET | 6895 | 2.05 |
01:26 ET | 18464 | 2.055 |
01:28 ET | 33977 | 2.055 |
01:30 ET | 1290 | 2.055 |
01:32 ET | 15745 | 2.07 |
01:33 ET | 33435 | 2.08 |
01:35 ET | 12792 | 2.08 |
01:37 ET | 9350 | 2.085 |
01:39 ET | 2800 | 2.085 |
01:42 ET | 49761 | 2.075 |
01:44 ET | 24465 | 2.09 |
01:46 ET | 3297 | 2.085 |
01:48 ET | 18673 | 2.085 |
01:50 ET | 4384 | 2.085 |
01:51 ET | 20660 | 2.08 |
01:53 ET | 17720 | 2.095 |
01:55 ET | 30746 | 2.095 |
01:57 ET | 13040 | 2.1 |
02:00 ET | 12299 | 2.095 |
02:02 ET | 25094 | 2.09 |
02:04 ET | 5902 | 2.095 |
02:06 ET | 10113 | 2.085 |
02:08 ET | 5176 | 2.08 |
02:09 ET | 16902 | 2.09 |
02:11 ET | 3425 | 2.095 |
02:13 ET | 4825 | 2.095 |
02:15 ET | 7595 | 2.11 |
02:18 ET | 25840 | 2.1 |
02:20 ET | 20168 | 2.105 |
02:22 ET | 26828 | 2.095 |
02:24 ET | 12473 | 2.105 |
02:26 ET | 7975 | 2.095 |
02:27 ET | 3447 | 2.095 |
02:29 ET | 46317 | 2.09 |
02:31 ET | 30909 | 2.095 |
02:33 ET | 15482 | 2.0868 |
02:36 ET | 27000 | 2.085 |
02:38 ET | 64456 | 2.095 |
02:40 ET | 1800 | 2.095 |
02:42 ET | 2986 | 2.095 |
02:44 ET | 7333 | 2.105 |
02:45 ET | 8180 | 2.105 |
02:47 ET | 11091 | 2.115 |
02:49 ET | 6915 | 2.115 |
02:51 ET | 2929 | 2.115 |
02:54 ET | 77495 | 2.125 |
02:56 ET | 5000 | 2.13 |
02:58 ET | 7189 | 2.125 |
03:00 ET | 1798 | 2.12 |
03:02 ET | 3300 | 2.13 |
03:03 ET | 7443 | 2.12 |
03:05 ET | 3400 | 2.12 |
03:07 ET | 13140 | 2.12 |
03:09 ET | 7923 | 2.115 |
03:12 ET | 38477 | 2.115 |
03:14 ET | 13354 | 2.11 |
03:16 ET | 6735 | 2.115 |
03:18 ET | 9755 | 2.1191 |
03:20 ET | 12999 | 2.13 |
03:21 ET | 24816 | 2.145 |
03:23 ET | 10372 | 2.145 |
03:25 ET | 41773 | 2.15 |
03:27 ET | 30518 | 2.15 |
03:30 ET | 29093 | 2.16 |
03:32 ET | 22494 | 2.16 |
03:34 ET | 32485 | 2.17 |
03:36 ET | 54509 | 2.175 |
03:38 ET | 15102 | 2.19 |
03:39 ET | 24176 | 2.1701 |
03:41 ET | 32267 | 2.195 |
03:43 ET | 50888 | 2.2 |
03:45 ET | 25035 | 2.1894 |
03:48 ET | 28366 | 2.1898 |
03:50 ET | 25740 | 2.185 |
03:52 ET | 41580 | 2.2 |
03:54 ET | 44435 | 2.191 |
03:56 ET | 112403 | 2.205 |
03:57 ET | 58967 | 2.21 |
03:59 ET | 277134 | 2.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ocugen Inc | 480.9M | -6.4x | --- |
Nautilus Biotechnology Inc | 479.2M | -8.3x | --- |
Praxis Precision Medicines Inc | 487.4M | -2.3x | --- |
Humacyte Inc | 485.2M | 2.7x | --- |
Imago BioSciences Inc | 471.6M | -10.5x | --- |
Vaxart Inc | 470.4M | -5.8x | --- |
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $480.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 215.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 4.54 |
EPS | $-0.35 |
Book Value | $0.48 |
P/E Ratio | -6.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.